GW Pharma

Trial failure for Jazz’s cannabis-derived drug blunts goal to expand its use to US
Fierce Pharma
Tue, 06/28/22 - 10:55 am
Jazz Pharma
cannabinoids
Epidiolex
GW Pharma
The top 10 biopharma M&A deals in 2021
Fierce Pharma
Tue, 01/18/22 - 10:53 am
M&A
CSL
Vifor
Jazz Pharmaeuticals
GW Pharma
Novo Nordisk
Dicerna
Horizon Therapeutics
Viela Bio
Perrigo
HRA Pharma
Sanofi
Kadmon
Merck
Acceleron
Pfizer
Arena Pharmaceuticals
Translate Bio
Trillium Therapeutics
Amgen
Five Prime Therapeutics
Midsize drugmakers have made more deals than large drugmakers this year
Beckers Hospital Review
Tue, 07/6/21 - 10:34 am
M&A
Jazz Pharma
GW Pharma
Jazz Pharmaceuticals' Acquisition of GW Pharmaceuticals Closes
Motley Fool
Wed, 05/5/21 - 09:55 pm
Jazz Pharma
GW Pharma
M&A
Quiet times return for biopharma takeouts
EP Vantage
Wed, 04/14/21 - 09:26 am
M&A
Alexion
Amgen
AstraZeneca
Biogen
Five Prime Therapeutics
Gilead Sciences
GW Pharma
Horizon Therapeutics
Immunomedics
Jazz Pharmaceutical
Kymab
Merck
Pandion
Sanofi
Viela Bio
Jazz CEO Bruce Cozadd campaigned for 6 months to buy GW Pharma. A 90% premium sealed the deal — along with $17.6M in ‘retention’ incentives
Endpoints
Sun, 03/7/21 - 01:33 pm
Jazz Pharmaceuticals
Pharma CEOs
Justin Glover
GW Pharma
M&A
Pharma’s pipeline continues to provide drama as investors look beyond COVID in Q4
Pharmaforum
Fri, 02/19/21 - 10:33 am
pharma industry
R&D
pandemic
earnings
COVID-19
Biogen
GW Pharma
Jazz Pharmaceuticals
GSK
Merck KGaA
GW Pharmaceuticals Beats on Revenue, Bottom Line for Q4
Motley Fool
Tue, 02/16/21 - 11:39 pm
GW Pharma
earnings
Jazz Pharma to acquire GW Pharma for $7.2 billion, adding CBD-based treatment for severe epilepsy
Stat
Wed, 02/3/21 - 10:58 am
Jazz Pharma
GW Pharma
M&A
CBD
epilepsy
Epidiolex
GW Pharma Hopes to Bring Its Second Cannabis-Based Drug to Market in the U.S.
BioSpace
Tue, 11/3/20 - 09:34 pm
GW Pharma
cannabindoids
multiple sclerosis
spasticity
nabiximols
Sativex
Ovid gets quick raise off PhII seizure results. Can the results hold up against GW?
Endpoints
Tue, 08/25/20 - 09:57 pm
Ovid Therapeutics
clinical trials
Takeda
Dravet syndrome
Lennox-Gastaut Syndrome
GW Pharma
GW Pharmaceuticals' Epidiolex Wins New FDA Approvals
Motley Fool
Mon, 08/3/20 - 11:33 pm
GW Pharma
Cannabidiol
Epidiolex
FDA
tuberous sclerosis complex
3 Biotech Stocks With Big Incoming Catalysts
Motley Fool
Sat, 07/25/20 - 02:25 pm
FDA
GW Pharma
Epidiolex
filgotinib
Galapagos
Biomarin
valoctocogene roxaparvovec
How GW Pharmaceuticals Hit a Home Run in Q1
Motley Fool
Tue, 05/12/20 - 11:48 am
GW Pharma
earnings
Epidiolex
GW Pharma tops list of UK R&D spenders
Pharmaforum
Wed, 02/19/20 - 09:46 am
GW Pharma
UK
R&D
Zogenix's Positive Clinical Trial Wasn't Positive Enough
Motley Fool
Sun, 02/9/20 - 04:08 pm
Zogenix
epilepsy
Lennox-Gastaut Syndrome
clinical trials
Fintepla
GW Pharma
Epidiolex
Zogenix hands GW a win
EP Vantage
Fri, 02/7/20 - 10:32 am
Lennox-Gastaut Syndrome
clinical trials
Fintepla
Zogenix
GW Pharma
GW Pharmaceuticals' Preliminary Q4 Revenue of $108 Million Beats Expectations
Motley Fool
Tue, 01/14/20 - 09:57 am
GW Pharma
earnings
Where Will GW Pharmaceuticals Be in 5 Years?
Motley Fool
Tue, 01/7/20 - 10:29 am
GW Pharma
cannabindoids
The Week Ahead In Biotech: ASH 2019 Gets Underway, Biogen's Aducanumab Data And More
Yahoo/Benzinga
Mon, 12/2/19 - 09:42 am
ASH2019
Roche
Bristol-Myers Squibb
Acadia Pharmaceuticals
Biogen
Cassava Sciences
Alector
GW Pharma
Magenta Therapeutics
Fortress Biotech
Mustang Bio
Bluebird Bio

Pages